Definition
US FDA substance register · UNII 722CLJ6H6K · registered name 2-Methyl-4'-(methylthio)-2-morpholinopropiophenone · single chemical substance
Methylthiophenyl Morpholino Isobutanone is the organic compound that conforms to the formula:
Cosmetic roles
Safety & regulatory references
- Banned
- ASEAN · European Union · United Kingdom
Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · MFDS (Korea) cosmetic regulatory information · UK cosmetics regulations (OPSS)
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
EU Cosmetics Regulation, Annex II (prohibited substances), entry 1592
Restriction II/1592
Source: EU CosIng ingredient list
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 71868-10-5
- EC No.EU chemical inventory number
- 400-600-6
- DTXSIDUS EPA chemical ID
- DTXSID8038857
- DTXCIDUS EPA compound ID
- DTXCID6018857
- IUPAC
- 2-Methyl-1-[4-(methylsulfanyl)phenyl]-2-(morpholin-4-yl)propan-1-one
- Molecular formula
- C15H21NO2S
- Molecular weight
- 279.4 g/mol
What products actually use it for
What the 18 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Photosensitizers12
- Processing aids not otherwise specified3
- Photosensitive agent2
- Binder1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
8 skin studies and 4 eye studies are on record.
The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 12 studies
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: OECD 404 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: US EPA s 163.81-5 "Primary dermal irritation study". Federal Register, Vol. 43, No. 163, August 22, 1978. according to - Classification not possible
Skin Irritation · Screening - Not likely to be sensitizing
skin sensitisation · Screening · according to other guideline: 79/831/EEC, Annex V, part B.417 (maximisation test) - Not likely to be sensitizing
skin sensitisation · Screening · according to other guideline: 79/831/EEC, Annex V, part B. 417 (maximisation test) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) modified - Classification not possible
Skin Sensitization · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: OECD 405 according to - Classification not possible
Eye Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: EPA, s 163.81-4 "Primary eye irritation study". Federal Register, Vol. 43, No. 163, August 22, 1978. according to
Source: US EPA CompTox dashboard
Linked databases 16
- ASEAN Cosmetic Directive
- Australian Industrial Chemicals Inventory (AICIS)
- ChEMBL
- EU CosIng ingredient list 2
- EU Cosmetics Regulation
- EU prohibited substances (Annex II)
- Korea toxic substances GHS register (NIER)
- MFDS (Korea) cosmetic regulatory information
- NIST Chemistry WebBook
- UK cosmetics regulations (OPSS)
- UniChem cross-reference IDs
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata